MONTREUX FIXED YIELD FUND

The Montreux Fixed Yield Fund seeks to acquire smaller businesses which do not meet the Montreux Healthcare Fund’s investment remit. These smaller businesses need additional time and investment to grow before they are sold. However, they often benefit from a high growth trajectory and a shorter investment time horizon. The fund is thematically similar to The Montreux Healthcare Fund but offers higher capital structure exposure, and a fixed yield over a three-year investment period.

WHY WE DO WHAT WE DO

The Montreux Fixed Yield Fund was established in response to an opportunity identified by our analysts. Smaller assets which could offer significant value to investors were often passed over as they did not meet the investment criteria of the Montreux Healthcare Fund Plc. but nonetheless, could offer good upside potential if purchased. An investment into the Montreux Fixed Yield Fund and The Montreux Healthcare Fund Plc. offers diversification to investors across different areas of the specialist care sector.

INVESTMENT STRATEGY

  • Fixed yield investment

  • Defensive sector with secure cashflows

  • Impact Investment

  • 3 year term

86%

MARKET FRAGMENTATION

3.4%

GROSS SPENDING CAGR

>90%

INDEPENDENT SECTOR SHARE OF KEY SERVICE PROVISIONS

Laing Buisson, 2022

 

Capital at risk. Past performance is not a reliable indicator of future performance. The value of investments and the income received from them can fall as well as rise, is not guaranteed and you may not get back the amount originally invested.

The Montreux Fixed Yield Fund Limited is an exempted limited liability company under the provisions of the Companies Law (as amended) of the Cayman Islands. The Fund’s NAV is calculated monthly independently of Montreux Capital Management Zug AG by Trident Trust Company (Cayman) Limited. It is an unregulated collective investment schemes (“UCIS”) for the purposes of the UK’s Financial Services and Markets Act 2000 (“FSMA”) and the promotion of a UCIS either within the UK or from the UK is restricted by FSMA. As such, details of the Fund on this website are directed only at persons who are Professional Clients or Eligible Counterparties as defined by the rules of the UK FCA.